Personal information

Other IDs

Scopus Author ID: 56469571000

Activities

Collapse all

Works (20)

Adiponectin profile at baseline is correlated to progression and severity of multiple sclerosis

European Journal of Neurology
2019 | Journal article
DOI: 10.1111/ene.13822
EID:

2-s2.0-85057486664
Contributors: Signoriello, E.; Lus, G.; Polito, R.; Casertano, S.; Scudiero, O.; Coletta, M.; Monaco, M.L.; Rossi, F.; Nigro, E.; Daniele, A.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study

Multiple Sclerosis Journal
2019 | Journal article
DOI: 10.1177/1352458518790390
EID:

2-s2.0-85052248047
Contributors: Saccà, F.; Lanzillo, R.; Signori, A.; Maniscalco, G.T.; Signoriello, E.; Lo Fermo, S.; Repice, A.; Annovazzi, P.; Baroncini, D.; Clerico, M. et al.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

Neurotherapeutics
2019 | Journal article
DOI: 10.1007/s13311-019-00776-7
EID:

2-s2.0-85071446493
Contributors: Clerico, M.; De Mercanti, S.F.; Signori, A.; Iudicello, M.; Cordioli, C.; Signoriello, E.; Lus, G.; Bonavita, S.; Lavorgna, L.; Maniscalco, G.T. et al.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery

PLoS ONE
2019 | Journal article
DOI: 10.1371/journal.pone.0222012
EID:

2-s2.0-85072331485
Contributors: Moccia, M.; Tajani, A.; Acampora, R.; Signoriello, E.; Corbisiero, G.; Vercellone, A.; Sergianni, P.; Pennino, F.; Lanzillo, R.; Palladino, R. et al.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Outcomes after fingolimod to alemtuzumab treatment shift in relapsing–remitting MS patients: a multicentre cohort study

Journal of Neurology
2019 | Journal article
DOI: 10.1007/s00415-019-09424-8
EID:

2-s2.0-85067685845
Contributors: Frau, J.; Saccà, F.; Signori, A.; Baroncini, D.; Fenu, G.; Annovazzi, P.; Capobianco, M.; Signoriello, E.; Laroni, A.; La Gioia, S. et al.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Clinical activity after fingolimod cessation: disease reactivation or rebound?

European Journal of Neurology
2018 | Journal article
DOI: 10.1111/ene.13694
EID:

2-s2.0-85050468337
Contributors: Frau, J.; Sormani, M.P.; Signori, A.; Realmuto, S.; Baroncini, D.; Annovazzi, P.; Signoriello, E.; Maniscalco, G.T.; La Gioia, S.; Cordioli, C. et al.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Fingolimod reduces the clinical expression of active demyelinating lesions in MS

Multiple Sclerosis and Related Disorders
2018 | Journal article
DOI: 10.1016/j.msard.2018.02.002
EID:

2-s2.0-85041547835
Contributors: Signoriello, E.; Doriana, L.; Fabrizia, M.; Francesco, S.; Gabri, N.C.; Fabio, B.; Francesco, S.; Alessandra, M.G.; Giuseppe, D.I.; Giacomo, L. et al.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Integrated cognitive and neuromotor rehabilitation in multiple sclerosis: A pragmatic study

Frontiers in Behavioral Neuroscience
2018 | Journal article
DOI: 10.3389/fnbeh.2018.00196
EID:

2-s2.0-85053331704
Contributors: Barbarulo, A.M.; Lus, G.; Signoriello, E.; Trojano, L.; Grossi, D.; Esposito, M.; Costabile, T.; Lanzillo, R.; Saccà, F.; Brescia Morra, V. et al.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Migraine as possible red flag of PFO presence in suspected demyelinating disease

Journal of the Neurological Sciences
2018 | Journal article
DOI: 10.1016/j.jns.2018.04.042
EID:

2-s2.0-85046800039
Contributors: Signoriello, E.; Cirillo, M.; Puoti, G.; Signoriello, G.; Negro, A.; Koci, E.; Melone, M.A.B.; Rapacciuolo, A.; Maresca, G.; Lus, G.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

Journal of Neurology
2018 | Journal article
DOI: 10.1007/s00415-018-9070-x
EID:

2-s2.0-85054011675
Contributors: Prosperini, L.; Annovazzi, P.; Boffa, L.; Buscarinu, M.C.; Gallo, A.; Matta, M.; Moiola, L.; Musu, L.; Perini, P.; Avolio, C. et al.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Palatability and oral cavity tolerability of THC:CBD oromucosal spray and possible improvement measures in multiple sclerosis patients with resistant spasticity: a pilot study

Neurodegenerative disease management
2018 | Journal article
DOI: 10.2217/nmt-2017-0056
EID:

2-s2.0-85058729124
Contributors: Lus, G.; Cantello, R.; Danni, M.C.; Rini, A.; Sarchielli, P.; Tassinari, T.; Signoriello, E.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study

Neurology
2017 | Journal article
DOI: 10.1212/WNL.0000000000004686
EID:

2-s2.0-85038017778
Contributors: Laroni, A.; Signori, A.; Maniscalco, G.T.; Lanzillo, R.; Russo, C.V.; Binello, E.; Lo Fermo, S.; Repice, A.; Annovazzi, P.; Bonavita, S. et al.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Diagnostic contribution of magnetic resonance imaging in an atypical presentation of motor neuron disease

Quantitative Imaging in Medicine and Surgery
2017 | Journal article
DOI: 10.21037/qims.2017.10.06
EID:

2-s2.0-85039840571
Contributors: Ugga, L.; Coppola, C.; Cocozza, S.; Saracino, D.; Caranci, F.; Tuccillo, F.; Signoriello, E.; Casertano, S.; Di Iorio, G.; Tedeschi, E.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis

Quantitative Imaging in Medicine and Surgery
2017 | Journal article
DOI: 10.21037/qims.2017.06.09
EID:

2-s2.0-85032833194
Contributors: Schettino, C.; Caranci, F.; Lus, G.; Signoriello, E.; Eoli, M.; Anghileri, E.; Pollo, B.; Melone, M.A.B.; Di Iorio, G.; Finocchiaro, G. et al.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)

PLoS ONE
2017 | Journal article
DOI: 10.1371/journal.pone.0180651
EID:

2-s2.0-85026820588
Contributors: Messina, S.; Solaro, C.; Righini, I.; Bergamaschi, R.; Bonavita, S.; Bossio, R.B.; Morra, V.B.; Costantino, G.; Cavalla, P.; Centonze, D. et al.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests

Multiple Sclerosis
2017 | Journal article
DOI: 10.1177/1352458516677592
EID:

2-s2.0-85026647892
Contributors: Saccà, F.; Costabile, T.; Carotenuto, A.; Lanzillo, R.; Moccia, M.; Pane, C.; Russo, C.V.; Barbarulo, A.M.; Casertano, S.; Rossi, F. et al.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis

Multiple Sclerosis
2016 | Journal article
DOI: 10.1177/1352458515604381
EID:

2-s2.0-84973455035
Contributors: Signoriello, E.; Lanzillo, R.; Brescia Morra, V.; Di Iorio, G.; Fratta, M.; Carotenuto, A.; Lus, G.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Treatment withdrawal in relapsing-remitting multiple sclerosis: A retrospective cohort study

European Journal of Neurology
2016 | Journal article
DOI: 10.1111/ene.12790
EID:

2-s2.0-84959305226
Contributors: Lus, G.; Signoriello, E.; Maniscalco, G.T.; Bonavita, S.; Signoriello, S.; Gallo, C.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome

Acta Neurologica Scandinavica
2015 | Journal article
DOI: 10.1111/ane.12357
EID:

2-s2.0-84922670364
Contributors: Signoriello, E.; Sagliocchi, A.; Fratta, M.; Lus, G.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Epstein barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment,Riattivazione dell’infezione da epstein barr virus come possibile trigger di cirrosi biliare-like syndrome in un paziente con sclerosi multipla in trattamento con fingolimod

Infezioni in Medicina
2014 | Journal article
EID:

2-s2.0-84920463353
Contributors: Marrone, A.; Signoriello, E.; Alfieri, G.; Mora, L.D.; Rinaldi, L.; Rainone, I.; Adinolfi, L.E.; Lus, G.
Source: Self-asserted source
Elisabetta Signoriello via Scopus - Elsevier

Peer review (3 reviews for 2 publications/grants)

Review activity for Journal of neurology. (2)
Review activity for Multiple sclerosis and related disorders. (1)
How many people are using ORCID?